Measles Vaccines
Live-attenuated vaccines (standalone and combination)
This page catalogs 5 standalone measles vaccine products. Today, measles antigen is almost exclusively administered via combination vaccines (MMR or MMRV). The original Edmonston B strain measles vaccine (1963) served as the foundation for all subsequent measles vaccines.
Note: For MMR and MMRV combination products, see the Combination Vaccines catalog.
Last updated: April 2026.
Measles Vaccine Catalog
| Trade Name | Generic Designation | Manufacturer | Vaccine Type | Regulatory Status & Year | Key Notes |
|---|---|---|---|---|---|
| Attenuvax | Measles virus vaccine, live-attenuated | Merck | Live-attenuated viral | FDA Licensed, 1963; Discontinued | Replaced by MMR |
| M-M-R II | Measles, mumps, rubella vaccine | Merck | Live-attenuated viral | FDA Licensed, 1978 | Standard MMR; see Combination Vaccines |
| Priorix | Measles, mumps, rubella vaccine | GSK | Live-attenuated viral | FDA Licensed, 2022 | Second US-licensed MMR |
| M-Vac | Measles vaccine | Various (historical) | Live-attenuated viral | Historical; Discontinued | Historical measles-only product |
| Mevilin-L | Measles vaccine | Various (historical) | Live-attenuated viral | Historical; Discontinued | Historical measles product |
Sources
Regulatory data sourced from FDA CBER Vaccines Licensed for Use in the United States (March 2026). Catalog scope and historical context informed by Khan, Shaz, The Ultimate Vaccine Timeline.